Liti is a technology company.
Liti has raised $6.0M across 2 funding rounds.
Liti has raised $6.0M in total across 2 funding rounds.
Liti has raised $6.0M in total across 2 funding rounds.
Liti's investors include Canary Ventures, CRV, Jenny Fielding, Scott Hartley, monashees, Felipe Villamarin, Simon Borrero, Hans Tung, Thrive Capital, David Vélez, Florian Otto.
# Liti: A Health Tech Company Addressing Latin America's Weight Management Crisis
Liti is a personalized health tech platform specializing in weight management and metabolic health for Latin America.[1][3] Founded in 2022 and based in São Paulo, Brazil, the company delivers a comprehensive online program combining medical consultations, nutritional planning, behavioral science support, and real-time health monitoring to help individuals achieve sustainable lifestyle changes.[1] Rather than a one-size-fits-all approach, Liti positions itself as the first consumer health tech company in Latam focused specifically on solving overweight and obesity through evidence-based medical practices.[3]
The company has demonstrated early traction in a high-growth market segment. Liti has raised $6.07M across seed-stage funding rounds, with its most recent $2M raise occurring approximately seven months ago.[1] Its investor base includes prominent Latin American venture firms such as Monashees+, Lupa Capital, and Endeavor Scale-Up Brazil, alongside 18 additional investors, signaling confidence in the company's market opportunity and execution.[1]
Liti emerged in 2022 during a period of growing recognition that obesity and metabolic health represent critical public health challenges in Latin America, yet remain underserved by digital health solutions.[1] The company was founded with a specific thesis: that personalized, medically-supervised online programs could democratize access to weight management care that was previously available only through expensive in-person consultations.
The founding team recognized that Latin America's large, underinsured population needed an alternative to traditional healthcare delivery models. By combining telehealth infrastructure with behavioral science and real-time monitoring, Liti positioned itself to capture a market segment that existing global health tech platforms had largely overlooked or underserved due to regional differences in healthcare systems, payment models, and cultural preferences.
Liti rides several converging trends reshaping healthcare globally. The digital health acceleration post-2020 normalized telehealth adoption across Latin America, creating infrastructure and consumer comfort that Liti leverages. Simultaneously, obesity prevalence in developing economies has accelerated faster than in developed markets, creating an urgent, underserved demand.
The company also benefits from Latin America's venture capital maturation. A decade ago, health tech funding in the region was sparse; today, firms like Monashees+ and Lupa Capital actively deploy capital into health tech, signaling that the ecosystem now recognizes healthcare as a venture-scale opportunity. Liti's success validates that personalized, medically-supervised digital health can achieve unit economics that work in emerging markets—a critical proof point for the broader category.
Additionally, Liti influences how global health tech companies think about regional adaptation. Rather than exporting U.S.-centric solutions, Liti demonstrates that building natively for Latin American healthcare systems, payment models, and cultural contexts can unlock significant value.
Liti is positioned at an inflection point. The company has achieved product-market fit signals (strong investor backing, rapid funding rounds) while operating in a market with structural tailwinds—rising obesity rates, improving digital infrastructure, and growing venture capital availability in Latin America.
The critical challenges ahead are scaling unit economics across a price-sensitive market and competing against better-capitalized global players (like Ro or Calibrate) if they enter Latin America. Liti's advantage lies in regional expertise and early-mover positioning; its risk is that global health tech platforms eventually localize and leverage superior capital and brand recognition.
Over the next 2-3 years, watch for Liti to expand beyond Brazil into other major Latin American markets (Mexico, Colombia, Argentina) and potentially raise a Series A to fund that expansion. If the company can demonstrate that personalized, medically-supervised digital health achieves strong retention and lifetime value metrics in emerging markets, it could become a template for how health tech scales in price-sensitive regions globally—and a potential acquisition target for larger health platforms seeking Latin American footholds.
Liti has raised $6.0M across 2 funding rounds. Most recently, it raised $4.0M Seed in November 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2022 | $4.0M Seed | Canary Ventures, CRV, Jenny Fielding, Scott Hartley, monashees, Felipe Villamarin, Simon Borrero | |
| Jan 1, 2022 | $2.0M Seed | CRV, monashees, Hans Tung, Thrive Capital, David Vélez, Felipe Villamarin, Florian Otto |